Key result
Nephrotic syndrome was associated with higher serum lipoprotein(a) levels compared to healthy controls.
Why the study?
Are serum Lp(a) levels elevated in patients with nephrotic syndrome compared to healthy controls?
Case-Control (n=52)
No
Are serum Lp(a) levels elevated in patients with nephrotic syndrome compared to healthy controls?
Serum Lp(a) levels are significantly elevated in patients with nephrotic syndrome, likely due to increased hepatic synthesis secondary to hypoalbuminemia, which may contribute to their increased risk of thrombotic complications.
Answers are grounded in this paper and cite their sources.
May link Lp(a) elevation to thrombotic risk in nephrotic syndrome; hypothesis-generating pending prospective outcome trials.
We investigated serum lipoprotein(a) [Lp(a)] levels in 20 patients with the nephrotic syndrome. Lp(a) levels in the nephrotic syndrome patients were significantly higher than those in a control group (30.4 +/- 22.5 vs 10.4 +/- 17.7 mg/dl). Overall, the serum Lp(a) and lipid levels showed no relationship, but on an individual basis the serum Lp(a) level varied with the serum levels of total cholesterol and low density lipoprotein cholesterol in the nephrotic syndrome patients. Our findings suggest that a decrease in serum albumin led to increased hepatic Lp(a) synthesis. It is well known that thrombotic disease supervenes on hypercoagulability in the nephrotic syndrome, so the determination of Lp(a) levels in these patients may provide information which is useful for preventing thrombotic complications.
No takes yet. Share an insight, caveat, or question.
Kanno et al. (1992) conducted a case-control in Nephrotic syndrome (n=52). Nephrotic syndrome vs. Healthy controls was evaluated on Serum Lipoprotein(a) levels (mg/dl) (p=<0.05). Nephrotic syndrome was associated with higher serum lipoprotein(a) levels compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: